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NOTE ON TERMS 
Throughout the thesis, several terms regarding heart disease will be used, sometimes 
interchangeably.   
  
Coronary heart disease_ comprises of angina, acute myocardial infarction and 
hypertension. It is also called Coronary Artery Disease CAD. 
 
Acute Myocardial infarction (AMI) _ an acute episode of CAD that leads to ischemia of 
heart muscle and its death  
 
Angina_ discomfort, heaviness, pressure, aching, burning, numbness, fullness, squeezing 
or painful feeling usually in chest 
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ABSTRACT 
Saadia Khizer 
Examination of gender differences in baseline characteristics and 12-month death and re-
hospitalization of African American patients admitted for Acute Myocardial Infarction 
(Under the direction of Dr. Karen Gieseker) 
 
 
Coronary heart disease, including acute myocardial infarction (AMI), is the nation’s 
leading cause of death. This study examined the characteristics and outcomes of 397 
African American (AA) patients within one year of hospitalization due to AMI at Grady 
Memorial Hospital (GMH) in Atlanta. The PREMIER study, a nationwide registry, 
maintained by John Spertus MD, included data from patient interviews, medical records, 
and clinical characteristics like diabetes, hypertension, smoking, angina frequency and 
quality of life was used. Patient characteristics, associated with a major adverse event 
(MAE) within one-year post AMI were evaluated using SAS. Results showed a trend of 
higher odds of younger age, hypertension, and diabetes in women than men at the time of 
hospitalization. Although this study did not show any gender differences in the outcomes 
of AA patients following AMI, a trend of effect modification by gender on various 
variables was seen. Further research is recommended to examine factors contributing to 
gender differences in outcomes after an AMI.  
 
Key Words: 
Acute myocardial infarction, heart attack, coronary artery disease, gender 
differences/disparities, African Americans 
EXAMINATION OF GENDER DIFFERENCES IN BASELINE CHARACTERISTICS 
AND 12 MONTH DEATH AND REHOSPITALIZATION OF AFRICAN AMERICAN 
PATIENTS ADMITTED FOR ACUTE MYOCARDIAL INFARCTION  
Chapter I-Introduction 
 
According to the American Heart Association about 1.2 million Americans will 
have a first or recurrent heart attack in 2007 and about 452,000 of these people will die. 
Coronary artery disease (CAD), which includes acute myocardial infarction (AMI), 
angina and hypertension, is the nation’s leading cause of death (American Heart 
Association 2006). Although often considered a men’s disease, CAD is a problem for 
women; in fact, more than 233,000 women die annually from coronary heart disease.  
Deaths from cardiovascular diseases in women exceed the total number of deaths caused 
by the next gender specific 16 causes of mortality.  
 A heart attack is called an acute myocardial infarction (AMI) in scientific 
language. The heart is a muscle that needs oxygen to survive. An AMI occurs when the 
blood flow that supplies oxygen to the heart muscle is severely reduced or cut off 
completely. This blockage is often a result of thickening and hardening of coronary 
arteries that supply the heart with blood from a buildup of fat, cholesterol and other 
substances that together are called plaque. The slow process of hardening of arteries over 
time is called atherosclerosis. The breaking off of plaque in a coronary artery can lead to 
the formation of a blood clot that can block the artery and shut off blood flow to the 
   
particular area of the heart muscle the artery supplies. When the heart muscle is starved 
for oxygen and nutrients, the process is called ischemia. Ischemia can be reversible, but 
prolonged ischemia leads to cellular death.  The death of part of the heart muscle as a 
result of ischemia is called an AMI.   
The National Registry of Myocardial Infarctions (NRMI) reports that women 
have worse outcomes than men after having an AMI (Lambrew and Bowlby 1997). Data 
show that women under the age of 50 have twice the mortality of men after having a 
heart attack (Vaccarino et al. 1998). It has been further shown that these variances likely 
reflect increased severity of the disease in younger women. Studies have shown an 
increased mortality rate in younger women compared to men after an AMI despite 
adjusting for medical history, clinical severity, hospital treatments and procedures (Ayus 
and Arieff 2001; Bodi et al. 2004; Daly et al. 2006; Holliday 2000; Franche et al. 2004; 
Jani et al. 2006; Vaccarino et al. 1999). 
Gender differences in mortality, short-term outcomes and symptom presentation 
following an AMI have been documented in the literature (Vaccarino et al. 1998; 
Vaccarino et al. 1999; Rosengren et al. 2001; Bodi et al. 2004). However, there has been 
limited research on gender differences in the AMI outcomes in the African American 
(AA) population. In order to specifically target interventions to AA men and women with 
AMI, gender differences in AMI outcomes in AA have to be studied.  
The understanding of gender differences in AMI outcomes may lead to more 
appropriately formed services to a minority population that already have poorer outcomes 
after AMI than Caucasian population (Sabatine et al. 2005; Skinner et al. 2005). The aim 
of the study was to examine gender differences in outcomes of the AA patients admitted 
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to Grady Memorial Hospital for AMI during the 12 months after an AMI.  This research, 
hypothesized that there would be gender differences in the outcomes of AA patients post 
AMI within one year after AMI. So the null hypothesis will be that gender differences do 
not exist in outcomes in this AA population within one year after AMI. To address the 
hypothesis, the following research questions were evaluated.  
1. Are there gender differences in characteristics of the AA patients admitted 
for an AMI? 
2. Do these gender differences affect the outcomes of the patients post AMI 
within 12 months of AMI? 
3. What is the contribution of gender, demographics, co-morbidities, pre- and 
post- AMI chest pain, and pre- and post- AMI quality of life to odds of 
having a major adverse event (i.e. being re-hospitalized or/and death) in 
first 12 months after AMI in AA patients? 
This study was unique since it focused exclusively on an AA population. The 
study examined if gender differences among AMI patients admitted to Grady Memorial 
Hospital, Atlanta, GA were similar to what has been documented for the total population 
in United States.   
Evidence on the gender differences in outcome of AMI patients in the total 
population, the racial disparities irrespective of gender in post AMI patients, and the 
usefulness of understanding of these gender differences are outlined in Chapter II – 
Review of Literature.  The process of systematically answering the research questions is 
discussed in Chapter III – Methods and Procedures, and answers to the research questions 
are found in Chapter IV – Results and Findings.  The thesis concludes with Chapter V - 
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Discussion and Conclusion, which involves interpretation of the data and subsequent 
recommendations for further research and for incorporating findings in public health.   
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Chapter II-Review of Literature 
 
Coronary artery disease (CAD) 
 CAD, also called coronary heart disease is the most common type of heart 
disease, affecting more than 13 million Americans annually (AHA. 2004). CAD is the 
result of the narrowing of the coronary arteries which occurs when the arteries become 
clogged, thereby restricting blood flow to the heart. Without adequate blood flow, the 
heart becomes starved of oxygen and the vital nutrients it needs to work properly. This 
thickening and hardening of coronary arteries, known as atherosclerosis, is caused by 
plaque formation, which results from a combination of buildup of fat, cholesterol and 
other substances.  
The most common symptom of CAD is angina or "angina pectoris." Angina can 
be described as a discomfort, heaviness, pressure, aching, burning, numbness, fullness, 
squeezing or painful feeling in the chest. It can be mistaken for indigestion or heartburn. 
Angina is usually felt in the chest, but also may be felt in the left shoulder, arms, neck, 
back or jaw. A diagnosis of angina requires determination of the likelihood of CAD and 
an assessment of the severity of presentation. The likelihood of significant CAD in 
patients presenting with acute chest pain syndrome is related to the physician's 
assessment of the patients' symptoms as angina, evidence of prior AMI or other 
indicators of CAD; and the sex, age, and number of major risk factors for atherosclerosis. 
CAD is comprised of high blood pressure (hypertension), angina (chest pain) and 
an AMI that is defined as an acute episode leading to ischemia of heart muscle. 
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Hypertension is defined as systolic pressure 140 mm Hg or greater and/or diastolic 
pressure 90 mm Hg or greater, taking antihypertensive medication, or being told at least 
twice by a physician or other health profession that person is hypertensive. According to 
National Health and Nutrition Examination Survey (NHANES) 1999-2004, in 2007 
15,800,000 people will suffer from CAD, 7,900,000 from AMI and 8,900,000 with chest 
pain or angina (Rosamond et al. 2007). 
  CAD causes roughly 1.2 million AMIs each year, and more than forty percent of 
those suffering from an AMI die. According to the American Heart Association, over 7 
million living Americans have suffered an AMI in their lifetime. Figure 2 shows the 
prevalence of CAD by age and gender. As can be seen from the figure, CAD is more 
prevalent in men than women of all age groups. 
 
 
 
 
 
Figure 1: Prevalence of CAD by age and sex (NHANES: 1999–2004). Source: NCHS 
and NHLBI. 
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CAD is the single largest killer of American males and females; about every 26 
seconds an American will suffer a coronary event, and about every minute someone will 
die from an AMI. Total mortality as a result of CAD was 452,300 in 2004 (Rosamond et 
al. 2007). 
According to the data from the National Center for Health Statistics (NCHS) and 
the National Heart, Lung, and Blood Institute (NHLBI), from 1994 to 2004 the death rate 
from CAD declined 33%; however the decline in actual number of deaths was only 18%. 
The death rate is decreasing but the raw number of people with CAD has increased and 
hence a smaller 18% decrease in deaths is seen. In 2004, the overall CAD death rate was 
150.5 per 100,000 population compared to 267.8 in 1999 (Donna L. Hoyert and Sherry L. 
Murphy 2001; Rosamond et al. 2007). The death rates per 100,000 in 2004 were 194.4 for 
white males and 222.2 for black males; for white females, the rate was 115.4, and for 
black females it was 148.6 (Rosamond et al. 2007). 
CAD comprises more than half of all cardiovascular events in men and women under 
age 75. The lifetime risk of developing CAD after age 40 years is 49% for men and 32% 
for women (AHA. 2004). The incidence of CAD in women lags behind men by 10 years 
for total CAD and by 20 years for more serious clinical events such as AMI and sudden 
death (AHA. 2004). 
 
Acute Myocardial Infarction (AMI)  
The term AMI is derived from myocardium (the heart muscle) and infarction 
(tissue death due to oxygen starvation). The phrase "heart attack" is sometimes used 
incorrectly to describe sudden cardiac death, which may or may not be the result of  AMI. 
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AMI is the irreversible necrosis of the heart muscle secondary to prolonged ischemia. 
AMI is the rapid development of myocardial necrosis caused by a critical imbalance 
between the oxygen supply and demand of the myocardium. Ischemia occurs when the 
heart muscle is starved for oxygen and nutrients. The death of part of the heart muscle as 
a result of ischemia is called an AMI (Elliot 2005). Figure 3 shows the process of plaque 
formation. 
 
Figure 2:  Plaque formation in coronary arteries 
 
www.medicinenet.com/heart_attack/article.htm
 
The estimated annual incidence of AMI is 565,000 new attacks and 300,000 
recurrent attacks annually (Boland 2002). Average age at first AMI is 65.8 years for men 
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and 70.4 years for women. Among Americans ages 40 to 74 years, NHANES data found 
the age-adjusted prevalence of self-reported AMI and electrocardiographically verified 
AMI to be higher among men than women but angina prevalence to be higher in women 
than in men. Age-adjusted rates of self-reported AMI increased among African-American 
men and women and Mexican-American men but decreased among white men and 
women from 1999 to 2004 (Lethridge-Cejku 2006). 
An AMI is diagnosed on the basis of symptoms like angina, changes in 
electrocardiogram (ECG) results and certain blood tests. The ECG is a noninvasive test 
that is used to reflect underlying heart conditions by measuring the electrical activity of 
the heart. Additional therapeutic decisions after diagnosis such as administration of an 
intravenous thrombolytic or performing percutaneous coronary intervention (PCI) often 
are made based on the severity of ECG changes. (Emedicine, 2006). 
  The classic symptoms of AMI include chest pain, shortness of breath, nausea, 
vomiting, palpitations, sweating, and anxiety or a feeling of impending doom. Patients 
frequently feel suddenly ill. Women often experience different symptoms than men. The 
most common symptoms of AMI in women include shortness of breath, weakness, and 
fatigue (McSweeney et al. 2003). Approximately one third of all AMIs are silent, without 
chest pain or other symptoms (Services and Medicine 1990).The risk of a recurrent AMI 
decreases through secondary prevention measures involving strict blood pressure 
management and lifestyle changes, chiefly smoking cessation, regular exercise, a sensible 
diet for patients with heart disease, and limitation of alcohol intake (AHA 2006). 
Cardiac markers also help to differentiate AMI from other causes of angina or 
chest pain. This categorization is valuable because patients with angina may or may not 
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have diagnostic changes on their ECG. The cardiac enzymes used in the diagnosis of 
AMI are troponin and creatine kinase isoenzyme (CKMB). CK-MB shows an increase 
above normal in a person's blood test about six hours after the start of a heart attack. It 
reaches its peak level in about 18 hours and returns to normal in 24 to 36 hours. The peak 
level and the return to normal can be delayed in a person who's had a large heart attack, 
especially if they don't get early and aggressive treatment. 
There are certain troponins specific to heart muscle whose presence in blood can 
detect minor heart muscle injury, which is not detected by CK-MB.  Normally the level 
of troponins in the blood is very low. It increases substantially within several hours (on 
average four to six hours) of muscle damage. It peaks at 10 to 24 hours and can be 
detected for up to 10 to 14 days (AHA 2006). Overall the combination of presentation, 
ECG changes and blood tests is critical for accurate diagnosis of an AMI. 
Patients are usually discharged post-AMI with several long-term medications that 
are designed to prevent secondary cardiovascular events (i.e. further AMIs, congestive 
heart failure or a cerebrovascular accident) (Brilakis, Reeder, and Gersh 2003). 
Depending on their gender and clinical outcome, people who survive the acute stage of an 
AMI have 1.5 to 15 times higher chances of illness and death than that of the general 
population. The risk of another AMI, sudden death, angina, heart failure, and stroke is 
substantial for both men and women (Rosamond et al. 2007). A Mayo Clinic study found 
that cardiac rehabilitation after an AMI is underused, particularly in women and the 
elderly. Women and elders were 55% less likely to participate in cardiac rehabilitation as 
compared to men and younger participants respectively (Witt et al. 2004). Only 32% of 
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men and women age 70 or older participated in cardiac rehabilitation, in comparison to 
66% of 60- to 69-year-olds and 81% of those under age 60 (Witt et al. 2004). 
On the basis of pooled data from the Atherosclerosis Risk in Communities 
(ARIC) Study, the Cardiovascular Health Study (CHS), the Framingham Heart Study 
(FHS), and studies of the National Heart Lung and Blood Institute (NHLBI) statistics 
indicate that 18% of men and 23% of women at age 40 and older die within one year after 
their first AMI.  At ages 40 to 69, 8% of white men, 12% of white women, 14% of black 
men, and 11% of black women die within first year.  At age 70 and older, 27% of white 
men, 32% of white women, 26% of black men, and 28% of black women  die within the 
same time frame (Rosamond et al. 2007).   
 
Risk factors of AMI 
According to the American Heart Association (AHA 2006) extensive clinical and 
statistical studies have identified several risk factors for coronary heart disease and AMI.  
Some are major risk factors (i.e., those that research has shown significantly increase the 
risk of heart and cardiovascular disease) while others are contributing risk factors (i.e., 
those associated with increased risk of cardiovascular disease, but for which significance 
and prevalence have not yet been precisely determined). Some of the risk factors can be 
treated, modified or controlled while others cannot. The more risk factors a person has, 
the greater the chance of having an AMI. Also, the greater the level of each risk factor, 
the greater the risk of occurrence of an AMI (Smith et al. 2001).   
The major risk factors for an AMI that cannot be changed are increasing age, 
male gender, genetics, and race (Sabatine et al. 2005; Conigliaro et al. 2000; Rosamond 
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et al. 2007). AA have more severe high blood pressure than Caucasians and a higher risk 
of heart disease (Douglas et al. 2003; Burt et al. 1995). AMI risk also is higher among 
Mexican Americans, American Indians, native Hawaiians and Asian Americans. This 
may be partly due to higher rates of obesity and diabetes in these populations (Douglas et 
al. 2003). Not surprisingly, most people with a strong family history of heart disease have 
one or more of the other risk factors as well (Rosamond et al. 2007). The major risk 
factors that can be modified, treated or controlled include smoking, high blood 
cholesterol, high blood pressure, physical inactivity, obesity, overweight and diabetes 
mellitus. Some of the contributing factors to these risks include stress and alcohol (Smith 
et al. 2001). Additionally depression has been found to be associated with greater risk for 
a subsequent cardiac event after AMI and a greater risk for death after the event (Parashar 
et al. 2006). 
Some racial and gender differences in the outcomes of AMI can be explained on 
the basis of distribution of the above-mentioned risk factors among various populations. 
Specifically, higher prevalence of hypertension, diabetes, and obesity among AA can be 
partially responsible for poor prognosis after AMI (Sonel et al. 2005). Moreover, in AA, 
the high prevalence of obesity and obesity-related conditions such as hypertension and 
type II diabetes, have been reported to contribute to their higher death rate from CAD. In 
addition, the high prevalence of obesity contributes to higher prevalence of hypertension 
in AA. AA have a more severe course of hypertension and an earlier onset of 
hypertension than Caucasians (AOA 2005; Burt et al. 1995). Interestingly, cultural 
factors related to dietary choices, physical activity, and acceptance of excess weight 
between AA and other racial-ethnic groups, appear to play a role in interfering with 
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weight loss efforts. Although both AA and whites report that they exercise less as they 
get older, AA women of all ages report participating in less regular exercise than white 
women (AOA 2005). This lack of physical activity in AA women can also be a factor in 
poorer outcomes after AMI. 
Studies have shown that there is an association between lower socioeconomic 
status (SES) and a worse AMI outcome. The SES encompasses the economic, social and 
physical environments in which individuals live and work, as well as the demographic 
and genetic factors. Measures for SES may include income, education, occupation, or 
employment. Patients of low SES have higher mortality after AMI compared to those 
who have higher SES in terms of income and access to healthcare (Alter et al. 2006; 
Chang 2007). Patients' baseline clinical status largely explained the relationship between 
SES and mortality among patients with AMI. The reasons for worse outcomes following 
AMI in groups with lower SES can be partially explained in part by greater co-
morbidities among persons with low SES. Although the association between low SES 
and other risk factors is not yet clearly understood which can be counted as a contributing 
risk factor (Alter et al. 2006; Bernheim et al. 2007; Lynch et al. 1996; Kraus, Borhani, 
and Franti 1980; Rahimi et al. 2007). 
                  
Racial differences in outcome of AMI patients 
 According to the findings from NHANES III 1999-2000 even though AMI 
declined 28% among whites, the decrease among blacks was only 19% (Douglas et al. 
2003). Despite modern treatments and advances in health care technology, racial 
disparities are observed in the prognosis of patients suffering from AMI (Conigliaro et al. 
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2000; Cooper et al. 2000; Douglas et al. 2003). Even after adjustment for baseline 
characteristics like age and gender, non-white patients had a significantly worse 
prognosis than white patients, regardless of treatment approach. Many studies also note 
that blacks are less likely than whites to receive many evidence-based treatments, 
particularly those that are costly or newer (Conigliaro et al. 2000; Sonel et al. 2005; 
Venkat et al. 2003). As mentioned earlier, the higher prevalence of hypertension, 
diabetes, and obesity among AA also contribute to poor prognosis in AA after AMI 
(Sonel et al. 2005). 
 
Gender differences in AMI 
CAD in women receives less attention as a cause of morbidity and mortality than 
in men (Eleanor Levin, 2005). Men have more coronary events in middle age in contrast 
to women, yet CAD is the leading cause of death in middle-aged women (Tunstall-Pedoe 
et al. 1996; Eaker et al. 1993). A mounting body of literature has described gender 
differences in symptom presentation, treatment and outcomes after AMI. CAD is present 
in one of nine women aged 45-64, and the ratio increases to one in three women after age 
of 65. CAD occurs approximately 10 years later for women than men, with the AMI 
occurring as much as 20 years later. Although men under 65 are more susceptible to AMI 
than women of comparable age, women in this age group who suffer from an AMI are 
more likely to die (Brezinka and Kittel 1996; Eaker et al. 1993). 
Overall, the characteristics and statistics of AMI are different in women than in 
men. Women with AMI are older at the time of the AMI than men, on average, by at least 
5 years. Women have different symptom presentation than men, and tests to detect AMI 
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function differently in women than in men (Greenland and Gulati 2006; Greenland et al. 
1991). Women are generally reported to have higher case fatality rates in the hospital, at 
30 days and 1 year after an AMI. Some attribute poorer outcomes in women to older age 
alone.  
Additionally, some studies suggest that women receive less intense approaches to 
treatment than men once they are recognized as having an AMI; this also contributes to 
poorer outcomes in women (Gan et al. 2000; Vaccarino et al. 2005). This less aggressive 
approach to treatment is in part responsible for adverse short term outcomes in women. 
Various studies observed significant gender differences in reports of several 
symptoms associated with acute coronary syndrome. These studies concluded that men 
are less likely to complain of neck pain, back pain, jaw pain, and nausea than women 
(Goldberg et al. 1998; Kam et al. 2002). Conversely, men are more likely to report 
diaphoresis than women. Women are more likely than men to report chest discomfort 
rather than chest pain and rate the severity of pain lower than men (Chen et al. 2005; 
McSweeney et al. 2003). 
Figure 3 shows the incidence of AMI by age, race and sex while Figure 4 shows 
the annual rate of first AMIs. Both incidence and rate are higher in Black men and 
women than White men and women. Women of both races however show lower 
incidence and annual rate compared to men 
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Figure 3: Incidence of AMI by age, race, and sex (ARIC Surveillance, 1987–2001). 
Source: NHLBI (Ross and Stier 1999)  
  
 
Figure 4: Annual rate of first AMIs by age, sex, and race (ARIC: 1987–2000). 
Source: NHLBI’s ARIC surveillance study, 1987–2000; . 
 
 
 
Most of the studies cited herein have adjusted for factors that influence outcome 
(e.g., age, diabetes and cardiac diagnosis). Studies therefore demonstrate that women may 
be more likely than men to experience atypical symptoms (e.g. chest discomfort rather 
than chest pain, pain/discomfort only in areas of the body other than the chest, 
pain/discomfort that first starts in the arm(s), and unexplained anxiety) associated with 
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AMI. Although difference in symptom presentation has been observed, it is not yet fully 
established if it has any association to the poorer outcomes post AMI in women (Kam et 
al. 2002; Chen et al. 2005; Goldberg et al. 1998; DeVon and Zerwic 2002; McSweeney et 
al. 2003). 
There is a marked difference in outcomes after AMI between men and women in 
different age groups. It has been demonstrated consistently that younger women have a 
particularly adverse prognosis compared with men, and this persists after the adjustment 
for risk factors (Vaccarino et al. 1998; Vaccarino et al. 2001; Vaccarino et al. 1999; 
Vaccarino et al. 2005). It has been widely accepted that the younger the age of the 
patients, the higher is the risk of death among women relative to men. Therefore although 
AMI affects men in greater numbers, the short-term outcomes for women are 
comparatively worse. (Vaccarino et al. 1999; Ayus and Arieff 2001; Vaccarino et al. 
2001; Rosengren et al. 2001; O¨zgu¨r, Belgin, and O¨ zgu¨r 2002).  
These gender differences are partially explained by greater co-morbidity in 
women which also leads to less frequent use of invasive procedures in women (Gottlieb 
et al. 2000; Simon et al. 2006; Mehilli et al. 2002). Studies showed that women with AMI 
are older, have more prevalence of hypertension and diabetes, thereby leading to lesser 
use of invasive procedures. The reason for lesser use of invasive procedures is less 
tolerance of surgery and lower success rates in the presence of these co-morbidities. 
These procedures have been shown to provide better outcomes after AMI but their lesser 
use in women can be responsible for poorer outcomes (Gottlieb et al. 2000).  
Disparities in management of AMI also may explain the gender differences in the 
outcomes post AMI. Comprehensive consideration of certain social, personal and medical 
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factors can explain some but not all gender and racial disparities in outcome of AMI 
(Sabatine et al. 2005; Iribarren et al. 2005). Rates of reperfusion therapy, coronary 
angiography, and in-hospital death after AMI vary according to race and sex (Skinner et 
al. 2005; Vaccarino et al. 2005). Numerous studies have shown that women with AMI are 
less likely to receive evidence-based care compared with men. According to AHA, there 
are eight evidence-based interventions for treatment and management of AMI patients 
once they are admitted to the hospital. These include prescription of aspirin and beta 
blocker medications at hospital arrival and discharge, prescription of enzyme inhibiting 
drugs, thrombolytic agent (medication to dissolve a blood clot blocking a heart artery) 
within 30 minutes of hospital arrival, angioplasty (opening of a blocked artery in the 
cardiac catheterization lab) within 120 minutes of hospital arrival and smoking cessation 
counseling (Mosca L 2004). 
The employment of evidence-based medicine reduces mortality in male and 
female patients with AMI. In addition it also leads to a decrease in mortality rates at one 
year post AMI. However, evidence-based procedures are used less often with women. 
Greater use of evidence based care and treatment in women might narrow the post-AMI 
sex mortality gap (Jani et al. 2006; Mehta et al. 2002).  
A number of studies have shown that women exhibit more delay in seeking care 
after AMI (Holliday 2000; Leslie et al. 2000; Gurwitz et al. 1997; Rosenfeld 2005; 
Bouma et al. 1999). Women's delay in seeking treatment for AMI symptoms results in 
higher rates of mortality and morbidity for women (Rosenfeld 2004). Since women 
usually have vague symptoms for AMI and often do not recognize them as a threat they 
delay in seeking care. According to a nursing study, women delayed presentation from 
 18
   
one hour to 168 hours (median 6.25 hours) (Holliday 2000). The decision to seek help 
was influenced by beliefs about personal susceptibility to AMI and beliefs about the way 
AMI presents (Holliday 2000). 
 In summary, the combination of older age at presentation, greater delays in 
seeking medical treatment and lower intensity of treatments after the hospitalization 
contribute to worse AMI outcomes in women. Even though gender differences have been 
established extensively for presentation, treatment and outcome of AMI, these differences 
have not been established exclusively in any minority population, including AA. This gap 
in literature served as a motivator to explore these gender differences in an exclusively 
AA population.  
 
Quality of life (QOL) measurements for AMI patients 
QOL is an important outcome measure after hospital admission for AMI. A 
number of predictors and measurements have been used in various studies. The physical 
and mental QOL scores of Short Form-36 (SF 36) have been used to identify clinical, 
demographic, and psychosocial characteristics of patients. The SF 36 is one of the most 
widely evaluated measurements. The SF 36 was developed in the US as part of the 
medical outcomes study and has been further tested and validated in a British population 
(Brown et al. 1999). 
 Another QOL measurement used in certain studies related to AMI is the MacNew 
Heart Disease Health-related Quality of Life Questionnaire (Stefan Höfer 2004). It has 
been shown to be specifically valuable for assessment of health status in heart disease for 
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individual patient. This assessment tool evaluates how daily activities and physical, 
emotional, and social functioning are affected by CAD and its treatment (Hofer S 2006). 
The Seattle Angina Questionnaire (SAQ) is a disease specific functional 
instrument that measures health related quality of life (QOL) outcomes. Its validity as a 
responsive, reliable, reproducible and prognostic measure of patients’ perspectives of 
how their coronary disease impacts their symptoms, function, satisfaction with treatment, 
and quality of life has been demonstrated (Spertus et al. 1995). SAQ is sensitive to 
clinical change and a valuable measure of outcome in cardiovascular research. It is a 19-
question self-administered instrument that measures five dimensions of CAD; Physical 
limitation scale, angina stability scale, angina frequency scale, treatment satisfaction 
scale, and disease perception/ quality of life (QOL) scale. 
 
Public Health and AMI 
CAD has been the leading cause of death in United States since 1921. Since 1950, 
age-adjusted death rates due to CAD have declined 60%, becoming one of the most 
important public health achievements of the 20th century (CDC 1999). Age-adjusted 
death rates per 100,000 persons for all diseases of the heart have decreased by 56%. Age-
adjusted death rates for CAD continued to increase into the 1960s, and then declined. In 
1996, 621,000 fewer deaths occurred from CAD than would have been expected had the 
rate remained at its 1963 peak (National Heart 1998). 
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Figure 5:  Mortality due to heart disease from 1990-1996 (CDC 1999). 
 Despite remarkable progress, CAD remains the leading cause of disability and 
death. Although many trends have been positive, trends for some important indicators of 
cardiovascular health such as risk of heart failure and stroke after AMI and obesity in 
adults have not improved substantially. 
According to CDC major public health challenges for the 21st century for CAD 
include reducing risk factor levels and preventing the development of adverse risk 
factors. Continued research is needed to understand the determinants (social, 
psychological, environmental, physiologic, and genetic) of CAD risk factors. The 
racial/ethnic disparities in CAD mortality have to be reduced. Promotion of policy and 
environmental strategies that enhance healthy behavior is essential. Identification of new 
 21
   
or emerging risk factors and determining their potential for public health intervention is 
also crucial (CDC 1999). 
Recent estimates suggest that cardiovascular diseases cost the United States $110 
billion annually. The average cost to traditional health insurers for the first 90 days 
following an AMI is $38,501. Medicare spends over $14,000 per patient on hospital bills 
in the year after an AMI, plus additional amounts for physicians and outpatient care. 
Moreover, these amounts are rising at a rate of four percent annually (David Cutler 
1998). 
Basically, a mounting body of literature shows that burden of AMI is heavier in 
AA population for both genders, compared to Caucasian population. They suffer in terms 
of higher incidence, prevalence and prognosis over time following an AMI and this is 
more true in the case of Black women. 
Some economic studies, focusing on AMI mortality, have shown that heart 
attacks are expensive to treat. It was concluded that the increasing intensity of medical 
treatment extends the lives of AMI patients (David Cutler 1998). Such treatment is also 
responsible for the increased costs. Also the clinical and economic burden of AMI is not 
limited to the acute event only but extends to post acute cardiac events over the years. 
Mean 10-year discounted inpatient medical costs for AMI patients have been shown to be 
in vicinity of $ 50, 000 (Eisenstein 2001).  
All this points to the fact that prevention of first AMI and then ensuing AMI will 
greatly contribute positively to public health. This can be achieved partly by educating 
the public about the symptoms, risks, seeking treatment and the secondary prevention 
after first AMI (Mosca et al. 2000). This study will be a first step in determining the 
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various contributing factors to the various outcomes of AMI in AA. A better 
understanding of these factors will lead to better health education about primary and 
secondary prevention of AMI. This will ultimately lead to the main goal of public health 
i.e. social justice, by reducing the health disparities by gender and race. 
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Chapter III-Methods and Procedures 
 
Objectives of the Thesis 
Having established the background on the CAD, gender differences in the 
symptoms, presentation and outcomes of an AMI, the remaining Chapters of the thesis 
will focus on specific research carried out by the author, which included secondary data 
analysis of data from one site (GMH) of a multi-center registry; the Prospective Registry 
Evaluating outcomes after Myocardial Infarction Events and Recovery (PREMIER) 
program. Patients were prospectively enrolled between January 1, 2003 and June 28, 
2004 from 19 U.S. hospitals as part of the PREMIER study. The data analyzed for this 
thesis was specific to AA AMI patients admitted to Grady Memorial Hospital (GMH) in 
Atlanta, Georgia in same time period.  
The objective of the study was to examine the gender differences in outcomes 
of the AA patients admitted with an AMI. The answers to the following research questions 
are pertinent to address this aim.  The data analysis addressed the following research 
questions: 
1. Are there gender differences in characteristics of the AA patients 
admitted with AMI? 
2. Do these gender differences affect the outcomes of the patients within 
12 months post AMI? 
 24
   
3. What is the contribution of gender, demographics, co-morbidities, pre- 
and post- AMI chest pain, and pre- and post- AMI quality of life to 
odds of being re-hospitalized and/or death in first 12 months after AMI 
in these AA patients? 
 
Background Research Description of the PREMIER Registry 
  The research questions were addressed by using data from PREMIER. The 
PREMIER Registry was created with funding from CV Therapeutics, Inc, Palo Alto, CA, 
and R-01 HS11282-01 from the Agency for Healthcare Research and Quality, Rockville, 
MD. The principal investigator for the GMH study site is Dr. Viola Vaccarino.    
Participants were prospectively enrolled between January 1, 2003 and June 28, 
2004 from 19 U.S. hospitals as part of the PREMIER study. The primary goal of 
PREMIER is to provide deep understanding of patients’ health status (presentation, QOL 
and function) one year after AMI. PREMIER identifies a broad number of insights into 
how current care might be improved to optimize patient centered health outcomes after 
AMI. It has been designed to explicitly describe patient-centered health status outcomes 1 
year after discharge and to document the determinants and trajectory of that recovery. It 
directly addresses an important knowledge gap in improving the patient-centered 
outcomes of AMI care. This will, in the long-term, lead to realization of the goals of the 
Institute of Medicine for improving the quality of American health care. 
All patients with positive troponin or elevated creatine kinase myocardial band 
fraction in the initial 24 hours of admission were screened for eligibility.  Subjects were 
included if they were ≥18 years of age, had elevated cardiac enzymes/biomarkers within 
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24 hours of arrival to the study hospital, and had additional clinical evidence of AMI (e.g. 
prolonged ischemic symptoms, and ST changes in the admitting electrocardiogram).   
Subjects were excluded if they were transferred to the study institution from another 
facility greater than 24 hours after their original presentation; were unable to provide or 
refused consent; did not speak English or Spanish; were discharged/expired before being 
contacted by the site coordinator; or were already enrolled in PREMIER and had a 
subsequent readmission.  
A comprehensive chart abstraction was performed at each site during the AMI 
admission to describe patient demographics, medical history, clinical status, hospital 
treatments and discharge recommendations. In addition, patients were interviewed during 
hospitalization to collect information on socio-demographic, behavioral, psychosocial 
and health status measures. The follow-up interviews were conducted 12 months after 
patient’s admission to reassess relevant clinical and behavioral characteristics by phone. 
The participants later selected for the contribution of risk factors and their changes over 
period of 12 months had most data available.  Figure 8 provides a schematic of the 
variables collected for the PREMIER registry. 
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Figure 6: Variables collected for the PREMIER registry (Spertus et al. 2006). 
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Secondary Data  
The data of PREMIER for GMH patients were obtained by permission of Dr. 
Susmita Parashar, the co-principal investigator of GMH site. GMH site had an existing 
SAS® (Statistical Analysis Software) database. There were a total of 440 AMI patients 
enrolled from GMH in Atlanta. Of these 440 patients, 397 AA patients were identified 
and selected for inclusion in this analysis. Patients had signed an informed consent at the 
time of enrollment and the Institutional Review Board of Emory University and Grady 
Research Oversight Committee approved the research protocol. The data used by the 
researcher were de-identified of names, date of birth and social security numbers to 
ensure the privacy of patients. 
 
Study Variables and Instruments 
 The following variables relevant to the research questions were included in the 
study dataset.  Gender was the self identified gender of the participant and was labeled 
male or female.   Age was measured in years and was obtained from the medical record.    
Education was measured as less than or more than high school according to patient’s 
response to the specific question. Smoking was defined by the patient’s response to the 
specific question asked regarding their smoking habits and labeled as current, former or 
never smoker. Hypertension, diabetes, hypercholesterolemia, prior AMI and family 
history of CAD were obtained from the medical records.  Angina frequency and quality 
of life were measured from the score of Seattle Angina Questionnaire (SAQ). 
. 
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For purposes of this thesis, two components of SAQ, (the angina frequency scale 
and QOL scale) were taken into account. The angina frequency score corresponds to 
questions 3 and 4 in SAQ that ask about frequency of chest pain over the last four weeks 
and frequency of taking nitroglycerine over the last four weeks. The responses are coded 
sequentially 1 to 6 in order of increasing health status, with 1 denoting the response 
associated with the lowest health status. If at least one question response is present then 
the angina frequency is computed by standardizing the mean response as follows: 
Angina Frequency = 100*(Mean Response – 1)/5 
The score is categorized as daily/weekly if it falls between 0 and 60, monthly if it falls 
between 70 and 90, and none if it is100.  
The QOL score corresponds to questions 9, 10 and 11 in the SAQ that ask about 
patient’s enjoyment of life over the last four weeks, satisfaction with chest pain and how 
worried they are about having a heart attack. The responses are coded sequentially 1 to 5 
in order of increasing health status, with 1 denoting the response associated with the 
lowest health status. If the responses to questions are not values 1, 2, 3, 4 or 5 then the 
response is set to missing. If at least two responses are present then the disease 
perception/QOL score is computed by standardizing the mean response as follows: 
Disease Perception = 100*(Mean Response – 1)/4 
The score is then categorized as poor/fair if it is less than 50, good if between 50 and 74, 
great if between 75 and 100, and excellent if it is100.  
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Adverse Outcome 
The outcome variable named Major Adverse Event (MAE) was a combination of 
all cause re-hospitalization and mortality. This was not restricted to deaths due to cardiac 
event only because dataset did not document cause of mortality. For re-hospitalization, if 
only those due to cardiac event were taken, it came to a very small number, thus all cause 
re-hospitalizations were also included. 
 
Statistical Analyses 
 The analysis was done using SAS Version 9.1. To describe the study sample, we 
performed independent t-tests and Pearson chi-square statistics to assess the differences 
across genders for continuous and categorical variables, respectively. The initial data set 
had 440 patients. When only the AA participants were selected the number reduced to 
397. So the study sample for the initial analysis comprised of 397 AA patients 
hospitalized with AMI.  
To address research questions univariate logistic regression and multivariate 
logistic regression analyses were performed. Results were documented with chi-square 
and odds ratio. For all of the statistical tests performed, p-values of .05 and 95% 
confidence intervals were used to determine the significance between the variables.  
In order to run these tests a further subset of 132 patients was created. These were 
the patients who had information for the time of hospitalization and over the period of 
one year following the AMI. These were the patients who were not lost to follow-up and 
had data for one month, six month or one year in addition to the baseline data at the time 
of hospitalization. These also included the patients who had either died or were 
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hospitalized over the period of one year. 
In order to determine the independent association of each covariate to gender, a 
univariate logistic regression analysis was performed. This univariate analysis provided a 
method for justifying our selection of each covariate into the multivariate analysis. For 
the multivariate analysis the same subset of 132 patients was used.  
 
Logistic regression 
 Multivariate analysis was performed on the subset of 132 patients who had a large 
amount of information at both the time of hospitalization with AMI and one year 
following it. Logistic regression can be used to predict a dependent variable on the basis 
of continuous and/or categorical independents and to determine the percent of variance in 
the dependent variable explained by the independents. This was done using forward 
selection method in SAS. In this method one variable is added at a time to the model to 
ascertain the significance of each variable independent of others. It also takes into 
consideration what change is brought by addition of new variable to the level of 
significance. 
The multivariate analyses tested all independent variables simultaneously to 
determine the association of gender with MAE adjusting for potential confounders (e.g. 
age, education, smoking, history of hypertension, diabetes etc.). The only difference in 
co-variables tested in multivariate, was that for SAQ QOL and angina frequency that 
score was taken which had been recorded the latest; whether it be at 6 months or one 
year. This was done to maintain the same sample size and to avoid any further reduction 
of sample size for analysis purposes. Variables analyzed included age, smoking, and 
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education, family history of CAD and past medical history of hypertension, diabetes, 
AMI or hypercholesterolemia. 
 Gender was analyzed in a manner that considered female sex as the exposure 
variable. Using a median split, age was analyzed as a dichotomous variable with age 
more than 56 years as the exposure variable. Education was also analyzed as 
dichotomous variable with having less than high school education as the exposure 
variable. Smoking was evaluated as a dichotomous variable with a positive history of 
smoking as the exposure variable. Similarly, history of hypertension, diabetes and 
previous AMI were analyzed each as dichotomous variable with presence of the history 
as exposure variable. The family history of CAD variable was also dichotomized with a 
positive family history of CAD as the exposure variable. Finally, the SAQ angina 
frequency and quality of life were analyzed as continuous variables. Considering the 
small sample size, SAQ score for both categories was analyzed from 12-month follow up. 
However if data for the 12-month follow up for a patient was missing then the SAQ score 
from the 6-month follow up of that patient was used. 
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Chapter IV- Findings and Results 
Descriptive characteristics of study population at baseline 
For the initial analysis for this thesis, 397 AA patients met the eligibility criteria 
at baseline that is time of hospitalization with AMI (Table1). Of these, 205 (52%) were 
men and 192 (48%) were women. The median age of the subjects was 56 years. The 
majority of subjects were non-or former smokers (65%), had more than high school 
education (56%) and an annual income of less than $10,000 (71%).  Moreover, the 
majority did not have co-morbidities like diabetes (62%) and hypercholesterolemia 
(81%), or family history of CAD (72%). However, there was a preponderance of patients 
with hypertension (84%). A majority of the patients did not report high frequency of 
angina (25%) or poor quality of life (12%) at the time of hospitalization with an AMI. 
Figure 7: The process of creating the final dataset and subset  
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GMH Baseline Patients
(N=440)
AA patients
(N=397)
Patients 
with both baseline
& 12-month data
(N=87)
Lost to follow up
(N=265)
Died
(N=45)
   
Table 1: Descriptive analysis of the study sample at baseline (N=397) 
 
Variable N (%) 
Sex   
Female 192 (48.4) 
Male 205 (51.6) 
Age   
56 and less 216 (54.4) 
Greater than 56 181 (45.6) 
Education   
Less than High School 172 (44.0) 
More than High School 219 (56.0) 
Income   
Less than 10,000 249 (70.5) 
More than 10,000 104 (29.5) 
Diabetes   
Yes 150 (38.0) 
No 245 (62.0) 
Prior MI   
Yes 108 (28.8) 
No 267 (71.2) 
Hypertension   
Yes 314 (83.7) 
No 61 (16.3) 
Hypercholesterolemia   
Yes 147 (39.2) 
No 228 (60.8) 
Family History of CAD   
Yes 104 (27.7) 
No 271 (72.3) 
Smoking   
Current 170 (43.0) 
Former 98 (24.8) 
Never 127 (32.2) 
SAQ Angina Frequency Category    
Daily/Weekly (0-60) 99 (24.9) 
Monthly (70-90) 140 (35.3) 
None (100) 158 (39.8) 
SAQ Quality of Life Category    
Poor-Fair (0-<50[1]) 162 (12.0) 
Good (50-<75) 168 (42.9) 
Great (75-<100) 41 (10.5) 
Excellent (100) 21 (5.4) 
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Tables 2 and 3 show the comparison of study patients when stratified by gender 
Table 2 shows the chi-square analysis and associated p-values, while Table 3 gives the 
odds ratio (OR) and 95 % confidence interval (CI). 
Nearly 56% of all the women were more than 56 years old while only 36% of the 
men were older than 56 years. Moreover, almost 45% of women had diabetes whereas 
only 32% men were diabetics. Almost 90% of women had hypertension compared to 
80% of men. Approximately 40% of women were non smokers compared to 24% of men. 
In addition, 37% of women were current smokers, compared to 50% of men who were 
current smokers. The distribution of the afore-mentioned variables i.e. age, hypertension, 
smoking and diabetes were statistically significant (all p<0.01). Comparatively, more 
women had hypercholesterolemia (45% vs. 35%) than men, but this was not statistically 
significant. Almost 70% of the patients had an annual income of less than $10,000 so this 
is mainly below poverty line population. 
 Additionally, women were almost as likely as men to have family history of 
CAD (30% vs. 26%) and prior history of an AMI (27% vs. 31%). Moreover there was no 
major difference among women and men in the two components of SAQ, the angina 
frequency scale and QOL scale.   
 Certain interesting results can be gleaned from the odds ratios in Table 3. In this 
study sample women with an AMI had less odds of being younger than 56 years of age.  
Female patients with AMI were 80% more likely to have diabetes than males with AMI 
(OR 1.3; 95% CI 1.1-1.6). Also, women with an AMI were significantly more likely to 
have hypertension (OR 2.2; 95% CI 1.1-1.7).and high cholesterol than males with an 
AMI respectively (OR 1.42; 95% CI 1.0-1.5). Interestingly, there was not much of a 
 35
   
difference among those with history of prior AMI with respect to suffering from an AMI. 
However, women with an AMI were 23% more likely to have family history of CAD 
compared to men with AMI. Women with AMI were 70% less likely to be current 
smoker (OR 0.3; 95% CI 0.1-1.2) and former smokers (OR 0.5; 95% CI 0.1-1.7) 
compared to men with an AMI but this was not statistically significant. 
 Conversely, women with an AMI did not have a difference in angina frequency 
and quality of life as measured by SAQ from men with an AMI. In summary women with 
an AMI had higher odds of being younger, having diabetes, hypertension, family history 
of CAD, smoking, and high cholesterol level compared to men with an AMI.  
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Table 2: Gender differences in characteristics of study sample from PREMIER 
registry at time of hospitalization with AMI (N=397) 
 
Variable N (%) 
Women 
N (%) 
Men 
Chi-
Square 
P-value 
Age     
56 and less 85  (44.3) 131 (63.9) 
Greater than 56 107 (55.7)  74  (36.1) 
15.4 < 0.001* 
Education     
Less than High School 83 (43.9) 89 (44.1) 
More than High School 106 (56.1) 113 (55.9) 
0.0 1.0 
Diabetes     
Yes 86 (44.8) 64 (31.5) 
No 106 (55.21) 139 (68.5) 
7.4 0.007* 
Income     
Less than $10,000 124 (72.9) 125 (68.3) 
More than  $10,000 46 (27.1) 50 (31.7) 
0.9 0.3 
Prior MI     
Yes 49 (26.6) 59 (30.9) 
No 135 (73.4) 132 (69.1) 
0.8 0.4 
Hypertension     
Yes 164 (89.1) 150 (78.5) 
No 20 (10.9) 41 (21.47) 
7.7 0.008* 
Hypercholesterolemia     
Yes 80 (43.5) 67 (35.1) 
No 104 (56.5) 124 (64.9) 
2.8 0.1 
Family History of CAD     
Yes 55 (29.9) 49 (25.7) 
No 129 (70.1) 142 (74.4) 
0.8 0.4 
Smoking         
current 71 (37.2) 99 (48.5) 
former 42 (22.0) 56 (27.5) 
never 78 (40.8) 49(24.0) 
12.8 0.002* 
SAQ Angina Frequency 
Category      
Daily/Weekly (0-60) 45 (23.4) 54 (26.3) 
Monthly (70-90) 71 (37.0) 69 (33.7) 
None (100) 76 (39.58) 82 (40.0) 
0.6 0.7 
SAQ Quality of Life Category      
Poor-Fair (0-<50[1]) 75 (40.0) 87 (42.7) 
Good (50-<75) 86 (45.7) 82 (40.2) 
Great (75-<100) 17 (9.0) 24 (11.8) 
Excellent (100) 10 (5.3) 11 (5.4) 
1.6 0.7 
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Table 3: Univariate analysis of study sample from PREMIER registry at time of 
hospitalization with AMI (N=397) 
 
 Variable N (%) Women N (%) Men OR 95% CI 
Age         
56 and less 85  (44.3) 131 (63.9) 0.5 0.3-0.7 
Greater than 56 107 (55.7)  74  (36.1) REF   
Education         
Less than High School 83 (43.9) 89 (44.1) 1.0 0.8-1.2 
More than High School 106 (56.1) 113 (55.9) REF   
Income         
less than 10,000 124 (72.9) 125 (68.3) 1.1 0.9-1.5 
more than 10,000 46 (27.) 50 (31.7) REF   
Diabetes         
Yes 86 (44.8) 64 (31.5) 1.8 1.1-1.6* 
No 106 (55.2) 139 (68.5) REF   
Prior MI         
Yes 49 (26.6) 59 (30.9) 0.8 0.7-1.1 
No 135 (73.4) 132 (69.1) REF   
Hypertension         
Yes 164 (89.1) 150 (78.5) 2.2 1.1-1.7* 
No 20 (10.8) 41 (21.5) REF   
Hypercholesterolemia         
Yes 80 (43.5) 67 (35.1) 1.4     1.0-1.5* 
No 104 (56.5) 124 (64.9) REF   
Family History of CAD         
Yes 55 (29.9) 49 (25.7) 1.2 1.0-1.4* 
No 129 (70.1) 142 (74.4) REF   
Smoking         
Current 10 (26.3) 19 (41.3) 0.3 0.1-1.2 
Former 15 (39.5) 19 (41.3) 0.5 0.1-1.7 
Never 13 (34.2) 8 (17.4) REF   
SAQ Angina Frequency 
Category          
Daily/Weekly (0-60) 45 (23.4) 54 (26.3) 0.9 0.5-2.2 
Monthly (70-90) 71 (37.0) 69 (33.7) 1.1 0.5-1.3 
None (100) 76 (39.6) 82 (40.0) REF   
SAQ Quality of Life Category          
Poor-Fair (0-<50[1]) 75 (39.9) 87 (42.7) 0.9 0.5-3.2 
Good (50-<75) 86 (45.7) 82 (40.2) 1.1 0.4-2.7 
Great (75-<100) 17 (9.0) 24 (11.8) 0.8 0.5-4.5 
Excellent (100) 10 (5.3) 11 (5.4) REF   
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Descriptive characteristics of study sample at one year 
 A subset of the baseline sample was created for further in-depth analysis. This 
subset consisted of those 132 patients who had data at both the baseline (time of 
hospitalization) and 12 months after an AMI. This dataset included the patients who had 
died over the year and this was the group with the information regarding the outcome 
variable MAE both at the baseline and over the period of 12 months post AMI. Tables 4 
& 5 present the gender differences in the subset population. Interestingly, there were no 
significant differences among men and women with an AMI in this subset sample (Table 
4). However, when OR with 95% CI were calculated (Table 5), women with an AMI had 
lower odds of being younger (OR 0.6; 95% CI 0.3-1.3) and higher odds of having 
hypertension (OR 2.3; 95% CI 1.0-2.0) compared to men with an AMI although this was 
not statistically significant. Women with an AMI had lower odds of having less than high 
school education compared to men (OR 0.9; 95% CI 0.8-1.5). Women with an AMI in 
this sample also had lesser odds of being current (OR 0.5; 95% CI 0.2-1.4) or former 
smokers compared to men (OR 0.6; 95% CI 0.2-1.6). Both men and women seemed to 
have similar frequency of angina at the time of hospitalization; however women with an 
AMI showed higher odds of higher angina frequency at one year post AMI compared to 
men (OR 2.6; 95% CI 0.5-12.2). Same was true for QOL at baseline and one year post 
AMI (similar in men and women at baseline and poorer in women at one year). 
 
 
 
 
 39
   
Table 4: Univariate Analysis at one year Post AMI in study sample subset (N=132) 
Variables N (%) 
Women 
N (%) 
Men 
Chi 
square 
P-
Value 
Age       
           <=56 27 (43.6) 39 (55.7) 0.2 
           >  56 35 (56.5) 31 (44.3) 
1.9 
  
Education     
    <High school 27 (45.0) 33 (48.5) 
    >High school 33 (55.0) 35 (51.5) 
0.2 0.7 
Income        
    <10,000 33 (63.5) 34 (60.7) 0.1 0.8 
    > 10,000 19 (36.5) 22 (39.3)     
Diabetes     
            Yes 31 (50.0) 25 (35.7) 
             No 31(50.0) 45 (64.3) 
2.7 0.1 
Prior MI     
          Yes 19 (30.7) 21 (30.0) 
          No 43 (69.3) 49 (70.0) 
0.0 0.9 
Hypertension     
          Yes 55 (88.7) 54 (77.1) 
           No 7 (11.3) 16 (22.9) 
3.1 0.1 
Hypercholosterolemia     
          Yes 22 (35.4) 26 (37.1) 
           No 40 (64.5) 44 (62.7) 
0.1 0.8 
Family History CAD     
          Yes 17 (27.4) 18 (25.7) 
           No 45 (72.6) 52 (74.3) 
0.1 0.8 
Smoking     
          Current 10 (26.31) 19 (41.3) 
          Former 15 (39.5) 19 (41.3) 
          Never 13 (34.2) 8 (17.4) 
2.5 0.3 
SAQ Angina Frequency at 
baseline 
    
           Daily 22(35.5) 22(31.4) 
           Monthly 18(29.0) 24(34.3) 
           None 22(35.5) 24(24.3) 
0.5 0.8 
SAQ Quality of Life at baseline     
          Poor 27 (45.8) 29 (42.0) 
          Good 26 (44.07) 25 (36.2) 
          Great 3 (5.08) 12 (17.4) 
          Excellent 3 (2.34) 3 (4.3) 
 
 
4.7 0.2 
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Variables N (%) 
Women 
N (%) 
Men 
Chi 
square 
P-
Value 
SAQ Angina Frequency at 1 
Month 
    
           Daily 5 (11.6) 6 (13.0) 
           Monthly 7 (16.3) 11 (23.9) 
           None 31 (72.1) 29 (63.0) 
0.9 0.6 
SAQ Quality of Life at 1 Month     
          Poor 8 (18.0) 4 (8.70) 
          Good 6(13.6) 11 (23.9) 
          Great 22 (51.2) 22 (47.8) 
          Excellent 7 (16.3) 9 (19.6) 
3.0 0.4 
SAQ Angina Frequency at 6 
Month 
    
             Daily 4 (9.3) 12 (23.5) 
             Monthly 4 (9.3) 6 (11.8) 
             None 35 (81.4) 33 (64.7) 
3.8 0.1 
SAQ Quality of Life at 6 Month     
          Poor 2 (5.13) 9 (18.0) 
          Good 8 (20.5) 13 (26.0) 
          Great 19 (48.7) 17 (34.0) 
          Excellent 10 (25.6) 11 (22.0) 
4.5 0.2 
SAQ Angina Frequency at 1 year         
           Daily 7 (15.2) 3 (6.25) 2.2 0.3 
           Monthly 8 (17.4) 11 (22.9)     
           None 31 (67.4) 34 (70.8)     
SAQ Quality of Life at 1 year     
          Poor 7 (17.1) 4 (8.5) 
          Good 5 (12.2) 5 (10.6) 
          Great 17 (41.5) 24 (51.1) 
          Excellent 12 (29.3) 14 (29.8) 
 
1.8 0.6 
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Table 5: Univariate analysis at one year Post AMI in study sample subset (N=132) 
 
Variables N (%) 
Women 
N (%) 
Men 
OR 95% CI 
Age         
           <=56 27 (43.6) 39 (55.7) 0.6 0.3-1.3 
           >  56 35 (56.5) 31 (44.3) REF   
Education         
    <High school 27 (45.0) 33 (48.5) 0.9 0.8-1.5 
    >High school 33 (55.0) 35 (51.5)  REF   
Income        
    < 10,000 33 (63.5) 34 (60.7) 1.1 0.7-1.4 
    > 10,000 19 (36.5) 22 (39.3)  REF   
Diabetes         
            Yes 31 (50.0) 25 (35.7) 1.8 0.5-1.1 
             No 31(50.0) 45 (64.3) REF   
Prior MI         
          Yes 19 (30.7) 21 (30.0) 1.0 0.7-1.5 
          No 43 (69.4) 49 (70.0)  REF   
Hypertension         
          Yes 55 (88.7) 54 (77.1) 2.3 1.0-2.0* 
           No 7 (11.3) 16 (22.9)  REF   
Hypercholosterolemia         
          Yes 22 (35.4) 26 (37.1) 1.0 0.7-1.5 
           No 40 (64.5) 44 (62.9)  REF   
Family History CAD         
          Yes 17 (27.4) 18 (25.7) 1.1 0.6-1.4 
           No 45 (72.6) 52 (74.3)  REF   
Smoking         
          Current 22 (36.0) 33 (47.1) 0.5 0.2-1.4 
          Former 19 (31.1) 22 (31.4) 0.6 0.2-1.6 
          Never 20 (32.8) 15 (21.4) REF   
SAQ Angina Frequency at baseline         
           Daily 22 (35.5) 22 (31.4) 1.1 0.5-2.5 
           Monthly 18 (29.0) 24 (34.3) 0.8 0.4-1.9 
           None 22 (35.5) 24 (24.3) REF  
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Variables N (%) 
Women 
N (%) 
Men 
OR 95% CI 
SAQ Quality of Life at baseline     
          Poor 27 (45.8) 29 (42.0) 0.9     0.2-5.0 
          Good 26 (44.1) 25 (36.2) 1.0     0.2-5.6 
          Great 3 (5.1) 12 (17.4) 0.3     0.1-2.0 
          Excellent 3 (2.3) 3 (4.4) REF   
SAQ Angina Frequency at 1 Month      
           Daily 5 (11.6) 6 (13.0) 0.2-2.9 
           Monthly 7 (16.3) 11 (23.9)     0.2-1.8 
           None 31 (72.1) 29 (63.0) 
0.8 
0.6 
REF  
SAQ Quality of Life at 1 Month 
 
      
 
          Poor 8 (18.0)   4 (8.7) 2.6 0.5-12.2 
          Good 6(14.0) 11 (23.9) 0.7 0.2-2.8 
          Great 22 (51.2) 22 (47.8) 1.3 0.4-4.1 
          Excellent 7 (16.3) 9 (19.6) REF  
SAQ Angina Frequency at 1 year       
           Daily 7 (15.2) 3 (6.3)     2.6 0.6-10.8 
           Monthly 8 (17.4) 11 (22.9)    0.8           0.3-2.2 
           None 31 (67.4) 34 (70.8) REF  
SAQ Quality of Life at 1 year         
          Poor 7 (17.1) 4 (8.5) 2.0 0.5-8.7 
          Good 5 (12.2) 5 (10.6) 1.2 0.3-5.0 
          Great 17 (41.5) 24 (51.1) 0.8 0.3-2.2 
          Excellent 12 (29.3) 14 (29.8) REF   
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Contribution of various co-variables to MAE 
The outcome variable for further analysis named Major Adverse Event (MAE) 
was a combination of all cause re-hospitalization and mortality. In the subset of 132 
patients, 41% had suffered an MAE within the year after an AMI. Table 6 presents the 
contribution of various demographic and risk factors to the incidence of MAE in the 
subset population by giving us the odds ratio and 95% CI. In the subset sample, 42% 
(n=26) of women and 40% (n=28) of men had suffered with MAE over the year. Women 
had slightly higher odds of suffering MAE compared to men although this was not 
statistically significant. Similarly, younger age also seemed to be associated more with 
occurrence of MAE over one year following AMI (OR 1.1; 95% CI 0.8-3.3) although 
again not statistically significant. Interestingly, patients suffering with MAE had 50% 
lesser odds of having less than high school education compared to those who did not have 
MAE (OR 0.5; 95% CI 0.2-1.0).  
Although patients with MAE had higher odds of having diabetes (OR 1.3; 95% CI 
0.6-2.6) , hypertension (OR 2.2; 95% CI 0.8-6.1) , higher cholesterol levels (OR 1.1; 95% 
CI 0.5-2.2) and being former smokers compared to those who did not have an MAE, none 
of these were statistically significant. Similarly, those suffering MAE had higher odds of 
reporting poorer quality of life at the time of hospitalization compared to those who did 
not, although this was not statistically significant (OR 3.5; 95% CI 0.4-31.8). Conversely, 
patients having MAE had lower odds of having a prior AMI (OR 0.6; 95% CI 0.3-1.3). 
Interestingly, patients having MAE had similar odds of having a positive family history 
of CAD to those who did not have MAE although this also was not statistically 
significant (OR 1.0; 95% CI 0.4-2.1).    
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Interestingly, although angina frequency at the time of hospitalization was not 
significantly associated with MAE, patients with MAE over the year showed 7.2 times 
more odds of having angina daily during the month after AMI compared to those who did 
not have MAE (OR 7.2; 95% CI 1.4-36.5) and this was statistically significant. Also, 
patients suffering with MAE over the year had higher odds of reporting poorer quality of 
life, at one (OR 3.5; 95% CI 0.4-31.8), six (OR 2.3; 95% CI 0.5-10.5),and 12 months 
(OR 1.8; 95% CI 0.4-7.5) post AMI, although none of these were statistically significant. 
Similarly, patients who had MAE over the year had higher odds of reporting having 
angina daily at six (OR 2.6; 95% CI 0.8-8.3) and 12 months (OR 2.9; 95% CI 0.7-12.2) 
post AMI, compared to those who did not have MAE, although none of these were 
statistically significant. 
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Table 6:  Univariate Analysis of Patients with Acute Myocardial Infarction (AMI) 
by MAE (Major Adverse Event) over one year post AMI (N=132) 
 
Variables MAE       
n (%) 
No MAE 
n (%) 
OR 95% CI 
Gender         
           Female 26 (48.2) 36 (46.2) 1.1 0.5-2.2 
               Male 28 (51.85) 42 (53.8) REF   
Age         
           <=56    31 (57.4) 35 (44.9) 1.7 0.8-3.3 
           >  56 23 (42.59) 43 (55.1) REF   
Education         
    <High school 19 (35.9) 41 (54.7) 0.5  0.2-1.0* 
    >High school 34 (64.2) 34 (45.3) REF   
Diabetes         
            Yes 25 (46.3) 31 (39.7) 1.3 0.6-2.6 
             No 29 (53.7) 47 (60.3) REF   
Prior MI         
          Yes 13 (24.1) 27 (34.6) 0.6 0.3-1.3 
          No 41 (75.9) 51 (65.4) REF   
Hypertension         
          Yes 48 (88.9) 61 (78.2) 2.2 0.8-6.1 
           No 06 (11.1) 17 (21.8) REF   
Hypercholesterolemia         
          Yes 20 (37.0) 28 (35.9) 1.1 0.5-2.2 
           No 34 (63.0) 50 (64.1) REF   
Family History CAD         
          Yes 14 (25.9) 21 (26.9) 1.0 0.4-2.1 
           No 40 (74.0) 57 (73.1) REF   
Smoking         
          Current 20 (37.0) 35 (45.5) 1.1 0.4-2.7 
          Former 22 (40.7) 19 (24.7) 2.2 0.9-5.6 
          Never 12 (22.2) 23 (29.9) REF   
SAQ Angina Frequency at 
baseline 
        
           Daily 16 (29.6) 28 (35.9) 0.9 0.4-2.0 
           Monthly 20 (37.0) 22 (28.2) 1.4 0.6-3.3 
           None 18 (33.3) 28 (35.9) REF   
SAQ Quality of Life at baseline         
          Poor 23 (45.1) 33 (42.9) 3.5 0.4-31.8 
          Good 20 (39.2) 31 (40.3) 3.2 0.4-29.7 
          Great 07 (13.7) 08 (10.4) 4.4 0.4-47.0 
          Excellent 01 (2.0) 05 (6.5) REF   
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Variables MAE n 
(%) 
No MAE 
n (%) 
OR 95% CI 
SAQ Angina Frequency at 1 
Month 
        
           Daily 09 (22.0) 02 (4.2) 7.2 1.4-36.5* 
           Monthly 09 (22.0) 09 (18.7) 1.6 0.6-4.6 
           None 23 (56.1) 37 (77.0) REF   
SAQ Quality of Life at 1 Month         
          Poor 07 (17.0) 05 (10.4) 1.8 0.4-8.2 
          Good 10 (24.4) 07 (14.6) 1.8 0.5-7.3 
          Great 17 (41.5) 27 (56.3) 0.8 0.3-2.5 
          Excellent 07 (17.0) 09 (18.8) REF   
SAQ Angina Frequency at 6 
Month 
        
             Daily 11 (22.5) 05 (11.1) 2.6 0.8-8.3 
             Monthly 07 (14.3) 03 (6.7) 2.8 0.7-11.7 
             None 31 (63.3) 37 (82.2) REF   
SAQ Quality of Life at 6 Month         
          Poor 07 (14.6) 04 (9.8) 2.3 0.5-10.5 
          Good 15 (31.2) 06 (14.6) 3.3 0.9-12.0 
          Great 17 (35.4) 19 (46.3) 1.2 0.4-3.5 
          Excellent 09 (18.8) 12 (29.3) REF   
SAQ Angina Frequency at 1 year         
           Daily 07 (15.2) 03 (6.3) 2.9 0.7-12.2 
           Monthly 10 (21.7) 09 (18.8) 1.4     0.5-3.8 
           None 29 (63.0) 37 (75.0) REF   
SAQ Quality of Life at 1 year         
          Poor 07 (15.9) 04 (9.1) 1.8 0.4-7.5 
          Good 03 (6.8) 07 (15.9) 0.4 0.1-2.0 
          Great 21 (47.7) 20 (45.5) 1.1 0.4-2.8 
          Excellent 13 (29.6) 13 (29.6) REF   
*statistically significant at <0.05 
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Gender stratification by MAE 
 For further in-depth analysis of relevant socio-demographic and risk factors, the 
subset population was stratified by gender. Table 7 gives us the contribution of 
demographic and risk factors, and the SAQ scores by showing OR and 95% CI in women 
while Table 8 shows the same for men. 
Contribution of co-variables in women 
Table 7 shows the contribution of various variables to having MAE over the year 
following AMI in women only of the study sample. This subset consists of 62 women. 
Women who suffered MAE over the year had twice the odds of being younger than 56 
compared to those who did not have MAE although this was not statistically significant.   
Although not statistically significant, women having MAE within the year after an 
AMI had twice the odds of having hypertension (OR 2.0; 95% CI 0.3-10.8), family 
history of CAD (OR 1.9; 95% CI 0.6-5.7) and former smoking (OR 2.1; 0.6-7.5). 
Interestingly, diabetes had no association with MAE in this subset sample although this 
was not statistically significant (OR 1.0; 95% CI 0.4-2.7).  
The women suffering with MAE had five times higher odds of experiencing 
angina monthly at the time of hospitalization, compared to those who did not have MAE 
(OR 5.3; 95% CI 1.4-20.9). This revealed a significant association between angina 
frequency at hospitalization and MAE. Although women who had MAE showed more 
odds of reporting higher angina frequency at one, six and 12 month than those who did 
not have MAE, none of these was statistically significant. This could be the result of 
decreasing sample size over time due to deaths. Similarly, women who had MAE had 
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twice the odds of reporting poorer QOL compared to those who did not have MAE but 
this was also not statistically significant. 
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Table 7:  Univariate Analysis of Women with Acute Myocardial Infarction (AMI) 
by MAE (Major Adverse Event) over one year post AMI (N=62) 
Variables MAE n 
(%) 
No MAE 
n (%) 
OR 95% CI 
Age         
           <=56 14 (53.8) 13 (50.0) 2.1 0.7-5.8 
           >  56 12 (46.2) 13 (50.0) REF   
Education         
    <High school 11 (42.3) 16 (47.1) 0.8 0.3-2.3 
    >High school 15 (57.7) 18 (52.1) REF   
Diabetes         
            Yes 13 (50.0) 18 (50.0) 1 0.4-2.7 
             No 13 (50.0) 18 (50.0) REF   
Prior MI         
          Yes      5 
(19.2) 
14 (38.9) 0.4 0.1-1.2 
          No 21 (80.8) 22 (61.1) REF   
Hypertension         
          Yes 24 (92.3) 31 (86.1) 2.0 0.3-10.8 
           No 02 (7.7) 05 (13.9) REF   
Hypercholosterolemia         
          Yes 08 (30.8) 14 (38.9) 0.7 0.2-2.0 
           No 18 (69.2) 22 (61.1) REF   
Family History CAD         
          Yes 09 (34.6) 08 (22.2) 1.9 0.6-5.7 
           No 17 (65.4) 28 (77.8) REF   
Smoking         
          Current 09 (34.6) 13 (37.2) 1.3 0.4-4.5 
          Former 10 (38.4) 09 (25.7) 2.1 0.6-7.5 
          Never 07 (26.9) 13 (37.2) REF   
SAQ Angina Frequency at 
baseline 
        
           Daily 08 (30.8) 14 (38.9) 1.5 0.4-5.4 
           Monthly 12 (46.2) 06 (16.7) 5.3 1.4-20.9* 
           None 16 (23.1) 16 (44.4) REF   
SAQ Quality of Life at baseline         
          Poor 13 (54.2) 14 (40.0) 1.9 0.2-23.0 
          Good 10 (41.7) 16 (45.7) 1.3 0.1-15.6 
          Great 00 (00.0)  03 (8.6)     0.0 
          Excellent   02 (4.1) 02 (5.7) REF 
 
 
 
 
 
    0.2** 
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Variables MAE 
 n (%) 
No MAE 
n (%) 
OR 95% CI 
SAQ Angina Frequency at 1 
Month 
      
             Daily 
  
 
04 (20.0) 01 (4.4) 6.3 0.6-63.6 
             Monthly 04 (20.0) 03 (13.1) 2.1  0.4-11.1 
             None 12 (60.0) 19 (82.6) REF   
         
SAQ Quality of Life at 1 Month         
          Poor 05 (25.0) 03 (13.1) 4.2 0.2** 
          Good 03 (15.0) 03 (13.1) 2.5 0.4** 
          Great 10 (50.0) 12 (52.2) 2.1 0.4** 
          Excellent 02 (10.0) 05 (21.7) REF   
SAQ Angina Frequency at 6 
Month 
        
             Daily 03 (13.0) 01 (5.0) 3.2  0.3-33.6 
             Monthly 03 (13.0) 01 (5.0) 3.2  0.3-33.6 
             None 17 (73.9) 18 (90.0) REF   
SAQ Angina Frequency at 1 year         
           Daily 05 (20.8) 02 (9.1) 2.7 0.5-15.9 
           Monthly 04 (16.7) 04 (18.2) 1.1   0.2-5.0 
           None 15 (62.5) 16 (72.7) REF   
SAQ Quality of Life at 1 year         
          Poor 05 (22.7) 02 (10.5) 2.5 0.3-18.3 
          Good 02 (9.1) 03 (15.8) 0.7 0.1-5.5 
          Great 09 (40.9) 08 (42.1) 1.1 0.3-4.9 
          Excellent 06 (27.3) 06 (31.6) REF   
 
* Statistically Significant at 0.05 
** Fisher’s exact test p-value 
 
 
 
 
 
 
 
 51
   
Contribution of co-variables in men 
Table 8 shows the contribution of various variables to having MAE over the year 
following AMI in men of the subset sample. This subset consists of 70 men. Age was no 
longer statistically associated with higher chances of suffering MAE in men. However, 
men having MAE had 70% smaller odds of having less than high school education 
compared to those who did not suffer MAE within the year after an AMI (OR 0.3; 95% 
CI 0.1-0.8).  
Although none of the other co-variables were statistically significant there were 
some interesting trends. Men who suffered MAE showed almost 2.5 times higher odds of 
having hypertension (OR 2.4; 95% CI 0.7-8.4). Similarly men who had MAE had higher 
odds of having diabetes (OR 1.7; 95% CI 0.6-4.5), high cholesterol level (OR 1.5; 95% 
CI 0.5-4.0) and former smoking (OR 2.4; 95%CI 0.7-9.4) than those who did not have 
MAE. Interestingly, those who suffered MAE had lesser odds of having history of prior 
AMI (OR 0.0; 95% CI 0.3-2.5) and family history of CAD (OR 0.5; 95% CI 0.2-1.6) 
compared to those who did not. 
The men, who suffered MAE within the year of AMI, showed a trend of 
association with higher odds of having higher angina frequency at almost all levels i.e. 
one(OR 8.2; 95% CI 0.8-79), six (OR 2.7; 95% CI 0.7-10.8) and a year (OR 2.9; 95% CI 
0.2-34.6)  post-AMI compared to those who did not suffer MAE.  
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Table 8:  Univariate Analysis of Men with AMI by MAE (Major Adverse Event) 
over one year post AMI (N=70) 
Variables MAE  
n (%) 
No MAE 
n (%) 
OR 95% CI 
Age         
           <=56 17 (60.7) 22 (52.4) 1.4 0.5-2.7 
           >56 11 (39.3) 20 (47.6) REF   
Education         
    <High school 08 (29.6) 25 (61.0) 0.3 0.1-0.8* 
    >High school 19 (70.3) 16 (39.0) REF   
Diabetes         
            Yes 12 (42.8) 13 (31.0) 1.7 0.6-4.5 
             No 16 (57.1) 29 (69.1) REF   
Prior MI         
          Yes 8 (28.5)  13 (31.0)  0.9 0.3-2.5 
          No 20 (71.4) 29 (69.1) REF   
Hypertension         
          Yes 24 (85.7) 30 (71.4) 2.4 0.7-8.4 
           No 04 (14.3) 12 (28.6) REF   
Hypercholesterolemia         
          Yes 12 (42.9) 14 (33.3) 1.5 0.5-4.0 
           No 16 (57.2) 28 (66.7) REF   
Family History CAD         
          Yes 05 (17.9) 13 (30.96) 0.5 0.2-1.6 
           No 23 (82.1) 29 (69.05) REF   
Smoking         
          Current 11 (39.3) 22 (52.3) 1.0 0.3-3.7 
          Former 12 (42.9) 10 (23.8) 2.4 0.7-9.4 
          Never 05 (17.9) 10 (23.8) REF   
SAQ Angina Frequency at baseline         
           Daily 08 (28.6) 14 (33.3) 0.6 0.2-1.9 
           Monthly 08 (28.6) 16 (38.1) 0.5 0.2-1.6 
           None 12 (42.9) 12 (28.6) REF   
SAQ Quality of Life at baseline         
          Poor 10 (37.0) 19 (45.2) 0.4  0.3-1.2 
          Good 
          Excellent 
10 (37.0) 
00 (0.00) 
15 (35.7) 
  03 (7.1) 
0.5 
0.0 
 0.1-2.4 
0.0-2.6 
          Great 07 (25.9) 05 (11.9)  REF   
     
SAQ Angina Frequency at 1 Month         
           Daily 05 (23.8) 01 (4.0) 8.2 0.8-79 
           Monthly            05 (23.8) 06 (24.0) 1.4 0.3-5.5 
           None 11 (52.4) 18 (72.0) REF   
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Variables MAE 
 n (%) 
No MAE 
n (%) 
OR 95% CI 
SAQ Quality of Life at 1 Month         
          Poor 02 (9.5) 02 (8.0) 0.8 0.1-8.5 
          Good 07 (33.3) 04 (16.0) 1.4 0.2-8.5 
          Great 07 (33.3) 15 (60.0) 0.4 0.1-1.8 
          Excellent 05 (23.8) 04 (16.0) REF   
SAQ Angina Frequency at 6 month         
             Daily 08 (30.8) 04 (16.0) 2.7 0.7-10.8 
Monthly 04 (15.4) 02 (8.0) 2.7 0.4-17.0 
             None 14 (53.9) 19 (76.0) REF   
SAQ Quality of Life at 6 Month         
          Poor 05 (19.2) 04 (16.6) 1.5 0.3-8.8 
          Good 07 (26.9) 06 (25.0) 1.4 0.3-7.0 
          Great 09 (34.6) 08 (33.3) 1.4 0.3-6.2 
          Excellent 05 (19.2) 06 (25.0) REF   
SAQ Angina Frequency at 1 year         
           Daily     02 (9.09) 01 (3.8) 2.9 0.2-34.6 
           Monthly   06 (27.3) 05 (19.2) 1.7 0.4-6.7 
           None   14 (63.6) 20 (76.9) REF   
SAQ Quality of Life at 1 year         
          Poor 02 (9.09) 02 (8.0) 1.0 0.1-9.2 
          Good 01 (4.6) 04 (16.0) 0.3 0.02-2.8 
          Great 12 (54.6) 12 (48.0) 1.0 0.3-3.7 
          Excellent 07 (14.9) 07 (28.0) REF   
          
*Statistically Significant at <0.05 
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Occurrence of MAE over the year following AMI 
Table 9 shows the results of the multiple logistic regression model which predicts 
the association of all the variables to MAE while adjusting for all other variables by 
giving OR and 95% CI in the subset population. Multivariate analysis was performed 
using multiple regression model; MAE= gender, age, hypertension, diabetes, 
hypercholesterolemia, prior AMI, family history of CAD, smoking, SAQ angina 
frequency and SAQ QOL. 
Women and men had an equal likelihood of suffering from MAE over one year 
after AMI. Women had lesser odds of suffering an AMI over the year compared to men; 
however this association was not statistically significant (OR 0.9; 95% CI 0.3-2.5). 
 Patients who had MAE within the year after AMI were 2.7 times as likely to be 
younger than 56 compared to those who did not have MAE (OR 2.7; 95% CI 1.1-6.9).  
Patients who suffered MAE had six times higher odds of being former smokers than 
those who did not have MAE (OR 6.11; 95% CI 1.4-27.5).   
Although for the other factors, 95% CI was not statistically significant there were 
number of interesting trends in the point estimates. Interestingly, patients who suffered 
MAE had fewer odds of having diabetes (OR 0.4; 95% CI 0.1-1.2). In addition, less than 
high school education showed a trend of being protective (OR 0.7; 95% CI 0.2-2.4).  
Surprisingly, those who suffered MAE had smaller odds of having a family 
history of CAD (OR 0.9; 95% CI 0.3-2.5), prior AMI (OR 0.6; 95% CI 0.2-2.0), and 
hypercholesterolemia (OR 0.7; 95% CI 0.2-2.4). In contrast, patients who had MAE had 
three times higher odds of having hypertension (OR 3.1; 95% CI 0.2-2.4).  
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As far as SAQ scores were concerned, although none of the associations were 
statistically significant, the analysis showed rather intriguing results. All patients who had 
suffered MAE, had lower odds of having angina daily at the time of hospitalization than 
those who did not suffer MAE (OR 0.77; 95% CI 0.2-3.4). In contrast, those who 
suffered MAE had 50% higher odds of having angina monthly at the time of 
hospitalization compared to those who did not suffer MAE (OR 1.5; 95% CI 0.4-6.0). 
Also, the patients with MAE had nine times higher odds of reporting poor SAQ QOL at 
the time of hospitalization compared to those who did not suffer MAE (OR 9.2; 95% CI 
0.6-133.3). The last recorded SAQ angina frequency, whether at 6 months or 12 months 
(OR 1.4; 95% CI 0.2-12.7), was also positively associated with having MAE. In contrast, 
strangely the SAQ QOL was negatively associated with MAE at all levels in the total 
sample.  
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Table 9:  Multivariate Analysis of Patients with Acute Myocardial Infarction (AMI) 
by MAE (Major Adverse Event) over one year post AMI (N=132) 
 
 
 
Variables MAE n 
(%) 
No MAE 
n (%) 
OR 95% CI 
Gender         
           Female 26 (48.1) 36 (46.2) 0.9 0.3-2.5 
              Male 28 (51.9) 42 (53.9) REF   
Age         
           <=56  31 (57.4) 35 (44.9) 2.7  1.1-6.9* 
           >  56 23 (42.6) 43 (55.1) REF   
Education         
    <High school 19 (35.9) 41 (54.7) 0.7  0.2-2.4 
    >High school 34 (64.2) 34 (45.3) REF   
Diabetes         
            Yes 25 (46.3) 31 (39.7) 0.4  0.1-1.2 
             No 29 (53.7) 47 (60.3) REF   
Prior MI         
          Yes 13 (24.0) 27 (34.6) 0.6      0.2-2.0 
          No 41 (75.9) 51 (65.4) REF   
Hypertension         
          Yes 48 (88.9) 61 (78.2) 3.1  0.7-14.2 
           No 06 (11.1) 17 (21.8) REF   
Hypercholesterolemia         
          Yes 20 (37.0) 28 (35.9) 0.7 0.2-2.4 
           No 34 (63.0) 50 (64.1) REF   
Family History CAD         
          Yes 14 (25.9) 21 (26.9) 0.9 0.3-2.5 
           No 40 (74.0) 57 (73.1) REF   
Smoking         
          Current 20 (37.0) 35 (45.5) 0.9 0.2-03.7 
          Former 22 (40.7) 19 (24.7) 6.1 1.4-27.5* 
          Never 12 (22.2) 23 (29.9) REF   
SAQ Angina Frequency at baseline         
           Daily 16 (29.6) 28 (35.9) 0.8 0.2-3.4 
           Monthly 20 (37.0) 22 (28.2) 1.5 0.4-6.0 
           None 18 (33.3) 28 (35.9) REF   
          
SAQ Quality of Life at baseline         
          Poor 23 (45.1) 33 (42.7) 9.2   0.6-133.3 
          Good 20 (39.2) 31 (40.3) 4.4 0.3-56.1 
          Great 07 (13.7) 08 (10.4) 6.5   0.4-108.1 
          Excellent 01 (2.0) 05 (6.5) REF   
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Variables MAE n 
(%) 
No MAE 
n (%) 
OR 95% CI 
SAQ Angina Frequency at 6-12 months         
          Daily 07 (13.5) 04 (7.8) 1.4   0.2-12.7 
          Monthly 12 (23.1) 09 (17.7) 1.2 0.3-4.9 
          None 33 (63.4) 38 (74.5) REF   
SAQ Quality of life at 6-12 months         
         Poor 07 (14.0) 04 (8.7) 0.9 0.1-7.1 
         Good 06 (12.0) 07 (15.2) 0.4 0.1-2.3 
         Great 22 (44.0) 21 (45.7) 0.9 0.3-3.0 
         Excellent 15 (30.0) 14 (30.4) REF   
*Statistically significant at <0.05   
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Chapter V-Discussion and Conclusion 
 
CAD in women receives less attention as a cause of morbidity and mortality than 
in men although it is the leading cause of death in middle-aged women. A mounting body 
of literature has described gender differences in symptom presentation, treatment and 
outcomes after AMI and the fact that an AMI occurs approximately 20 years later for 
women than men. Although men under 65 are more susceptible to AMI than women of 
comparable age, women in this age group who suffer from an AMI are more likely to die 
(Bodi et al. 2004). Previous studies have shown that the combination of older age at 
presentation, greater delay in seeking medical treatment and lower intensity of treatments 
after the hospitalization apparently all contribute to poorer outcomes in women. 
 
Gender differences at the time of hospitalization with AMI 
 The data of patients at the time of hospitalization shows some interesting results. 
An interesting finding is that men who were admitted with AMI are younger than their 
female counterparts. This is in accordance with the studies and science showing that AMI 
occurs almost 20 years later for women than men. This fact stays true in case of this study 
sample.  
 Women in this population are not only older but also have greater odds of being 
diabetic, hypertensive, having higher cholesterol level and family history of CAD. Age is 
a factor that plays a role in having more diabetes in women. All above mentioned 
variables are known risk factors of AMI and the data shows it is true in this population 
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also. The data also strengthens the concept that those who present with above mention 
co-morbidities have higher likelihood of having an AMI. Hypertension has been shown 
to be more prevalent in AA population. Looking at the total population, hypertension was 
prevalent in this AA sample also. Hypertension was also associated with higher trend of 
poorer prognosis after AMI in AA. 
 It was expected to find an association between higher angina frequency 
and women; it did not show up significantly in the results. This however changes in later 
results. The knowledge component might be contributing to this lack of association at the 
time of hospitalization. The patients might not have been able to recognize angina as a 
threat or a symptom therefore unable to associate it with AMI, especially at the time of 
first AMI. Also studies suggested that the tendency of women to not complain of severity 
of chest pain as quickly as men might be contributory to this lack of association at the 
time of hospitalization. This coincides, to a degree, to previous literature that women 
suffer or report lesser chest pain intensity than men. Comparatively, more women 
reported poorer QOL at the time of hospitalization with AMI than men. 
 The subset sample of 132 patients (who had data both at the time of 
hospitalization and six and/or one year) also showed interesting results. Men are still 
younger in this sample though not statistically significantly so because of smaller sample 
size. The gender differences noted in prevalence of certain risk factors held true for this 
sample also despite the smaller size. Certain risk factors, such as high cholesterol in 
women at the time of hospitalization, no longer showed positive association in the subset 
population.  Conversely, both diabetes and hypertension stayed higher in women than 
men in both samples. This slight difference might be due to loss to follow-up of those 
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who were younger or had high cholesterol. Another reason could be that patients less 
than 56 years, crossed over to older age group or they controlled their cholesterol with 
diet and medicines. In the subset sample more women reported poorer quality of life at 
one month compared to men. This change in reporting might have been brought by 
higher awareness of the symptoms like angina in women after an AMI. 
 
Contribution of various variables to MAE 
 When the study sample of 132 patients was stratified by MAE, certain interesting 
associations between various variables and MAE were revealed. Gender was not 
associated with the major adverse event in the total population. Younger age, though not 
statistically significant, seems to be associated with poor outcomes. This has been shown 
in the literature; younger patients especially younger women have a poor prognosis after 
AMI. 
The relationship of poor outcome after an AMI and education was the most 
fascinating finding in this population. Those with less than a high school education had 
better outcomes over the year after AMI compared to those with more than a high school 
education. This can be related to the fact that those who have less than a high school 
education may get more physically challenging jobs compared to individuals with higher 
education levels. This may keep them in better physical shape thereby protecting them 
from an AMI. Women who are more educated might take it a sign of weakness to show 
their angina and inadvertently delay their hospital arrival. The awareness of heart disease 
in women and its consequences is a key to overcoming this factor as has been shown by 
previous studies. Although not statistically significant (probably due to smaller sample 
 61
   
size) diabetes, hypertension and high cholesterol levels showed a trend of being 
associated with poorer outcomes.  
Angina frequency, when reported daily after one month of AMI was a very strong 
predictor of poor outcome in total population. The patients whether male or female, who 
had angina daily one month after AMI, showed  higher chances of a poorer outcome. 
This high association did not stay statistically significant at six month or 12-month even 
though point estimate was still very high. This might be attributed to loss of these patients 
to death in short term and also to the subsequent smaller sample size. Angina frequency 
has been shown to be associated with AMI in previous studies and seems to be a strong 
predictor in this population. This association did not stay significant when men and 
women were analyzed separately, which may be a result of the smaller sample size. 
 
Gender differences in the outcome of patients 
 When the major adverse event was stratified by gender, the results changed from 
those of the total population. Looking at various results, even though gender is not 
directly or blatantly associated with worse outcomes in the study population; it comes 
into play while interacting with other variables. Although the results for certain variables 
are not statistically significant, when the subset sample is stratified by gender, these 
variables show effect modification. There seems to be a trend that gender is impacting 
outcome of AMI by effect on variables.  
 Effect modification means that the degree of association between an exposure and 
outcome differs in different subgroups of the population. The variables showing most 
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effect modification in this study by gender include age, education, diabetes, hypertension 
QOL at baseline and angina frequency at baseline and one month after an AMI. 
 Younger age of women seems to be more highly associated with poor outcome 
compared to men. This study therefore shows what has been previously established in 
literature. Similarly, higher angina frequency, both at baseline and one month after AMI, 
shows greater association with poor outcome in women compared to men. Women also 
showed a trend of association of poorer QOL at baseline and worse outcomes compared 
to men. 
 Conversely hypertension, diabetes and high cholesterol level seem to have greater 
association with poor outcome following an AMI in men compared to women. This again 
is not statistically significant probably due to small sample size and needs further 
elucidation by in depth studies that explore interaction between gender and these risk 
factors. 
 The multivariate analysis does not show any association between gender and poor 
outcomes after an AMI. However younger age is significantly associated with poor 
outcomes. At the time of hospitalization with AMI although more women were in older 
age group than men, majority of those who experienced MAE were in younger age group. 
This has been shown time and again that younger women suffer poorer prognosis after 
AMI in the short term. 
Although smoking was not shown to have any statistical significance in prior 
analysis, former smokers turned out to be strongly associated with poor outcome after an 
AMI over a period of one year. This can be attributed to the idea that former smokers 
were comparatively heavy smokers or they had quit recently.   
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 The logistic regression on women of the subset sample while controlling for 
other factors revealed significant association between poorer QOL at the time of 
hospitalization and poor outcomes following an AMI which was statistically significant. 
This was similar to the total sample of both men and women as explained earlier. 
However, this was not the case for the men only sample while adjusting for all other 
factors. Conversely, the men only analysis showed significant association between poor 
prognosis and higher frequency of angina at one year. The significant relationship 
between QOL and poor outcomes ceased to exist in men and was replaced by higher 
frequency of angina at the time of hospitalization. This might lead to the speculation that 
either men are better reporters of angina or that they experience more intense angina as a 
symptom of AMI compared to their women cohorts. Studies have also shown angina to 
occur more often in men than women in the total population. The study shows that this 
may be true for this AA sample also.  
 
Limitations of the study data 
 The biggest limitation of the study is sample size. This is a small sample and the 
subset created for further analysis was even smaller. This was done partly due to high rate 
of loss to follow up. It is not therefore known as to what were the outcomes of patient 
who were lost to follow up. A further study can be done to compare the baseline 
characteristics of those who were lost to follow up and those who stayed in the study. 
Gender was not directly associated with poor outcomes; however a trend of effect 
modification was revealed which can be further elucidated by more studies of a larger 
sample. The patients who were lost to follow up might have been very different from the 
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patients who remained in the study. Various causes leading to their loss to follow-up 
might be directly or indirectly related to the findings of the study thereby influencing the 
outcomes in unexpected manner. 
 Another limitation can be that all these are only GMH patients; thereby maybe 
different from rest of AA population in terms of SES. These patients belonged to low 
SES i.e. below the poverty line. The dynamics working there and affecting the outcomes 
of AMI can be inherently different from the total population. Lower SES although not 
directly related to AMI and its outcomes can affect this sample in different ways that are 
not yet properly understood. Understanding of these interactions between lower SES and 
AA sample dynamics could be crucial to the further elucidation of the factors leading to 
various outcomes post AMI. This study was also limited to only one hospital, so the 
results might be generalized to only a population similar to this study population. 
 
Strengths of the study 
 The major strength of the study is its AA population. This study is unique in the 
sense that although all predictors and variables have been studied in both AA and 
Caucasian populations, this has not been done in an exclusive AA population. So racial 
disparity is not part of equation in this particular sample and thereby might provide better 
insight into the outcomes of AMI.  Moreover not only for AA but also for population in 
general, this study provides a focused group to analyze significance of various risk 
factors and predictors in a comparatively controlled population sample. 
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Conclusion 
 The study failed to show a direct association between gender and poor outcomes 
following an AMI in this AA sample. However, the study does show that gender is an 
effect modifier for various variables like age and education along with risk factors like 
diabetes, hypertension and high cholesterol level and their association with poorer 
outcomes following an AMI in this AA population. This needs to be examined in depth 
and in a larger sample size in order to further elucidate the interaction between gender 
and various variables. Gender differences exist in the characteristics of the AA 
population at the time of hospitalization. Some differences exist in higher prevalence of 
existing co-morbidities like diabetes, hypertension and high cholesterol level in women 
that have been previously established in total population, while others like less than high 
school education warrant further research. Relationship of experiencing angina frequency 
daily after one month of AMI in both men and women warrants further research and 
analysis in a bigger population.  
 This study points out the concept that any health education and interventions for 
better outcomes of AMI in AA should be focused uniquely for gender. The optimum 
results for any health education or public health intervention in this area can be achieved 
if they are gender-specific and this study points us to need of further understanding of 
gender dynamics happening after an AMI in AA population. The education and 
awareness of significance of various co-morbidities and angina in public in general, and 
AMI patients in particular may prove to be a major step towards improving the outcomes 
after AMI. Public health is all about social justice and equity whether it is in public 
setting or clinical setting. The ultimate goal of public health is to improve the health of 
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masses with a multidisciplinary approach. Improving the outcomes of the post-AMI AA 
patients should include educating the masses by increasing awareness about risk factors 
and symptom presentation while keeping in mind the existing baseline gender and racial 
disparities. 
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